Canada Pension Plan Investment Board lowered its stake in Humana Inc. (NYSE:HUM - Free Report) by 51.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 188,853 shares of the insurance provider's stock after selling 203,326 shares during the period. Canada Pension Plan Investment Board owned 0.16% of Humana worth $47,914,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in the company. Global Endowment Management LP grew its position in shares of Humana by 7.7% during the fourth quarter. Global Endowment Management LP now owns 1,827 shares of the insurance provider's stock worth $464,000 after acquiring an additional 131 shares during the last quarter. Insigneo Advisory Services LLC lifted its position in shares of Humana by 17.3% in the 4th quarter. Insigneo Advisory Services LLC now owns 1,360 shares of the insurance provider's stock valued at $345,000 after acquiring an additional 201 shares in the last quarter. Dodge & Cox grew its position in Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Adams Wealth Management lifted its holdings in shares of Humana by 24.3% in the fourth quarter. Adams Wealth Management now owns 9,717 shares of the insurance provider's stock valued at $2,465,000 after purchasing an additional 1,899 shares in the last quarter. Finally, AGP Franklin LLC purchased a new stake in Humana in the 4th quarter worth about $1,506,000. Institutional investors and hedge funds own 92.38% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on HUM shares. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Mizuho boosted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. StockNews.com upgraded shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Finally, Robert W. Baird boosted their price target on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Humana currently has a consensus rating of "Hold" and an average price target of $284.90.
Check Out Our Latest Stock Analysis on HUM
Humana Stock Performance
Shares of Humana stock traded up $4.76 during mid-day trading on Wednesday, hitting $263.68. 1,081,378 shares of the stock were exchanged, compared to its average volume of 1,660,029. The company has a market capitalization of $31.82 billion, a P/E ratio of 26.50, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a 50-day simple moving average of $265.74 and a 200 day simple moving average of $270.19. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.
Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's payout ratio is 35.58%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.